Prenatal carrier screening has expanded to include a large number of genes offered to all couples considering pregnancy or with an ongoing pregnancy. Expanded carrier screening refers to identification of carriers of single-gene disorders outside of traditional screening guidelines. Expanded carrier screening panels include numerous autosomal recessive and X-linked genetic conditions, including those with a very low carrier frequency, as well as those with mild or incompletely penetrant phenotype. Therefore, the clinical utility of these panels is still subject of debate. Priority should be given to carrier screening panels that include a comprehensive set of severe childhood-onset disorders. Psychosocial support and genetic couseling should be available prior to screening and for the return of positive results. Systems are needed to reduce the risk of misinterpreting results. Finally, attention should be paid on the impact of expanded carrier screening on health care organizations and burden of cost.
Expanded carrier screening: A current perspective / Mastantuoni, Enrica; Saccone, G; Al-Kouatly, Hb; Paternoster, M; D'Alessandro, Pietro; Giuliani, Arduino; Carbone, Luigi; Esposito, G; Raffone, A; DE VIVO, Valentino; Maruotti, Gm; Berghella, V; Zullo, F.. - In: EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY. - ISSN 0301-2115. - 230:(2018), pp. 41-54. [10.1016/j.ejogrb.2018.09.014]
Expanded carrier screening: A current perspective
MASTANTUONI, ENRICA;Saccone G;Paternoster M;D'Alessandro, Pietro;Arduino B;CARBONE, LUIGI;Raffone A;DE VIVO, VALENTINO;Maruotti GM;Zullo F.
2018
Abstract
Prenatal carrier screening has expanded to include a large number of genes offered to all couples considering pregnancy or with an ongoing pregnancy. Expanded carrier screening refers to identification of carriers of single-gene disorders outside of traditional screening guidelines. Expanded carrier screening panels include numerous autosomal recessive and X-linked genetic conditions, including those with a very low carrier frequency, as well as those with mild or incompletely penetrant phenotype. Therefore, the clinical utility of these panels is still subject of debate. Priority should be given to carrier screening panels that include a comprehensive set of severe childhood-onset disorders. Psychosocial support and genetic couseling should be available prior to screening and for the return of positive results. Systems are needed to reduce the risk of misinterpreting results. Finally, attention should be paid on the impact of expanded carrier screening on health care organizations and burden of cost.File | Dimensione | Formato | |
---|---|---|---|
10.1016@j.ejogrb.2018.09.014.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Documento in Pre-print
Licenza:
Dominio pubblico
Dimensione
395.38 kB
Formato
Adobe PDF
|
395.38 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.